Analytical Method Development / GMP
Expert analytical method development, validation, and transfer services across all therapeutic modalities and regulatory frameworks.
Analytical methods are the technical foundation of pharmaceutical quality assurance and regulatory compliance. The quality of a pharmaceutical product — and the ability to demonstrate that quality to regulatory authorities — depends entirely on the quality of the analytical methods used to measure it. The development of robust, specific, sensitive, and reproducible methods is a critical quality and regulatory function.
For Quality Control Managers, the development and validation of methods to the appropriate regulatory standard — whether ICH Q2(R2) for conventional pharmaceutical methods, ICH M10 for bioanalytical methods, or specific guidelines applicable to biologics, oligonucleotides, or gene therapy products — is a fundamental operational requirement.
AMSbiopharma provides comprehensive analytical method development, validation, and transfer services across the full range of techniques and regulatory frameworks applicable to pharmaceutical development, working collaboratively with sponsor teams.
Discover
Our catalog of services include
Analytical Method Development, Validation, and Transfer
Our method development services begin with a comprehensive understanding of the analytical challenge: the physicochemical properties of the analyte, matrix complexity, regulatory context, and performance requirements. Based on this foundation, we design analytical methods optimized for sensitivity, specificity, accuracy, and robustness.
Method validation is performed in accordance with applicable regulatory guidelines — ICH Q2(R2) for quantitative pharmaceutical methods and ICH M10 for regulated bioanalytical methods — covering all required validation parameters: specificity, linearity, range, accuracy, precision, detection and quantification limits, robustness, and stability. Complete validation reports are prepared in a regulatory-ready format.
Method transfer services ensure that validated methods perform consistently in receiving laboratories, through an interlaboratory comparability exercise demonstrating equivalent performance. Transfer documentation complies with applicable regulatory requirements.
Key analytical capabilities:
– Method development for HPLC, UHPLC, GC, LC-MS/MS, HRMS, and other analytical platforms
– Full validation in accordance with ICH Q2(R2), ICH M10, and applicable specific guidelines
– Validation for small molecules, peptides, biologics, and oligonucleotides
– Method transfer with interlaboratory comparability and regulatory documentation
– Phase-appropriate validation strategies for early- and late-stage development programs